Literature DB >> 25954027

RAN translation at CGG repeats induces ubiquitin proteasome system impairment in models of fragile X-associated tremor ataxia syndrome.

Seok Yoon Oh1, Fang He1, Amy Krans1, Michelle Frazer1, J Paul Taylor2, Henry L Paulson1, Peter K Todd3.   

Abstract

Fragile X-associated tremor ataxia syndrome (FXTAS) is a neurodegenerative disorder caused by a CGG trinucleotide repeat expansion in the 5' UTR of the Fragile X gene, FMR1. FXTAS is thought to arise primarily from an RNA gain-of-function toxicity mechanism. However, recent studies demonstrate that the repeat also elicits production of a toxic polyglycine protein, FMRpolyG, via repeat-associated non-AUG (RAN)-initiated translation. Pathologically, FXTAS is characterized by ubiquitin-positive intranuclear neuronal inclusions, raising the possibility that failure of protein quality control pathways could contribute to disease pathogenesis. To test this hypothesis, we used Drosophila- and cell-based models of CGG-repeat-associated toxicity. In Drosophila, ubiquitin proteasome system (UPS) impairment led to enhancement of CGG-repeat-induced degeneration, whereas overexpression of the chaperone protein HSP70 suppressed this toxicity. In transfected mammalian cells, CGG repeat expression triggered accumulation of a UPS reporter in a length-dependent fashion. To delineate the contributions from CGG repeats as RNA from RAN translation-associated toxicity, we enhanced or impaired the production of FMRpolyG in these models. Driving expression of FMRpolyG enhanced induction of UPS impairment in cell models, while prevention of RAN translation attenuated UPS impairment in cells and suppressed the genetic interaction with UPS manipulation in Drosophila. Taken together, these findings suggest that CGG repeats induce UPS impairment at least in part through activation of RAN translation. Published by Oxford University Press 2015. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25954027      PMCID: PMC4492395          DOI: 10.1093/hmg/ddv165

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  75 in total

1.  Genetic modifiers of tauopathy in Drosophila.

Authors:  Joshua M Shulman; Mel B Feany
Journal:  Genetics       Date:  2003-11       Impact factor: 4.562

Review 2.  Myotonic dystrophy.

Authors:  Charles A Thornton
Journal:  Neurol Clin       Date:  2014-06-06       Impact factor: 3.806

3.  Subunit compositions and catalytic properties of proteasomes from developmental temperature- sensitive mutants of Drosophila melanogaster.

Authors:  J A Covi; J M Belote; D L Mykles
Journal:  Arch Biochem Biophys       Date:  1999-08-01       Impact factor: 4.013

4.  Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy.

Authors:  Rahul N Kanadia; Jihae Shin; Yuan Yuan; Stuart G Beattie; Thurman M Wheeler; Charles A Thornton; Maurice S Swanson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-24       Impact factor: 11.205

Review 5.  Repeat-associated non-AUG translation and its impact in neurodegenerative disease.

Authors:  Michael G Kearse; Peter K Todd
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

6.  Improved activities of CREB binding protein, heterogeneous nuclear ribonucleoproteins and proteasome following downregulation of noncoding hsromega transcripts help suppress poly(Q) pathogenesis in fly models.

Authors:  Moushami Mallik; Subhash C Lakhotia
Journal:  Genetics       Date:  2010-01-11       Impact factor: 4.562

7.  Pur alpha binds to rCGG repeats and modulates repeat-mediated neurodegeneration in a Drosophila model of fragile X tremor/ataxia syndrome.

Authors:  Peng Jin; Ranhui Duan; Abrar Qurashi; Yunlong Qin; Donghua Tian; Tracie C Rosser; Huijie Liu; Yue Feng; Stephen T Warren
Journal:  Neuron       Date:  2007-08-16       Impact factor: 17.173

8.  Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein.

Authors:  Sovan Sarkar; Janet E Davies; Zebo Huang; Alan Tunnacliffe; David C Rubinsztein
Journal:  J Biol Chem       Date:  2006-12-20       Impact factor: 5.157

9.  Histone deacetylases suppress CGG repeat-induced neurodegeneration via transcriptional silencing in models of fragile X tremor ataxia syndrome.

Authors:  Peter K Todd; Seok Yoon Oh; Amy Krans; Udai B Pandey; Nicholas A Di Prospero; Kyung-Tai Min; J Paul Taylor; Henry L Paulson
Journal:  PLoS Genet       Date:  2010-12-09       Impact factor: 5.917

10.  C9orf72 FTLD/ALS-associated Gly-Ala dipeptide repeat proteins cause neuronal toxicity and Unc119 sequestration.

Authors:  Stephanie May; Daniel Hornburg; Martin H Schludi; Thomas Arzberger; Kristin Rentzsch; Benjamin M Schwenk; Friedrich A Grässer; Kohji Mori; Elisabeth Kremmer; Julia Banzhaf-Strathmann; Matthias Mann; Felix Meissner; Dieter Edbauer
Journal:  Acta Neuropathol       Date:  2014-08-14       Impact factor: 17.088

View more
  55 in total

Review 1.  New pathologic mechanisms in nucleotide repeat expansion disorders.

Authors:  C M Rodriguez; P K Todd
Journal:  Neurobiol Dis       Date:  2019-06-21       Impact factor: 5.996

Review 2.  Molecular Pathophysiology of Fragile X-Associated Tremor/Ataxia Syndrome and Perspectives for Drug Development.

Authors:  Teresa Botta-Orfila; Gian Gaetano Tartaglia; Aubin Michalon
Journal:  Cerebellum       Date:  2016-10       Impact factor: 3.847

Review 3.  [Fragile X associated tremor/ataxia syndrome: its clinical presentation, pathology, and treatment].

Authors:  M J Salcedo-Arellano; R J Hagerman; V Martinez-Cerdeno
Journal:  Rev Neurol       Date:  2019-03-01       Impact factor: 0.870

4.  Calcium dysregulation and Cdk5-ATM pathway involved in a mouse model of fragile X-associated tremor/ataxia syndrome.

Authors:  Gaëlle Robin; José R López; Glenda M Espinal; Susan Hulsizer; Paul J Hagerman; Isaac N Pessah
Journal:  Hum Mol Genet       Date:  2017-07-15       Impact factor: 6.150

5.  Selective rescue of heightened anxiety but not gait ataxia in a premutation 90CGG mouse model of Fragile X-associated tremor/ataxia syndrome.

Authors:  Hoanna Castro; Emre Kul; Ronald A M Buijsen; Lies-Anne W F M Severijnen; Rob Willemsen; Renate K Hukema; Oliver Stork; Mónica Santos
Journal:  Hum Mol Genet       Date:  2017-06-01       Impact factor: 6.150

6.  Granulosa cell and oocyte mitochondrial abnormalities in a mouse model of fragile X primary ovarian insufficiency.

Authors:  Carola Conca Dioguardi; Bahar Uslu; Monique Haynes; Meltem Kurus; Mehmet Gul; De-Qiang Miao; Lucia De Santis; Maurizio Ferrari; Stefania Bellone; Alessandro Santin; Cecilia Giulivi; Gloria Hoffman; Karen Usdin; Joshua Johnson
Journal:  Mol Hum Reprod       Date:  2016-03-09       Impact factor: 4.025

Review 7.  Recent advances in assays for the fragile X-related disorders.

Authors:  Bruce E Hayward; Daman Kumari; Karen Usdin
Journal:  Hum Genet       Date:  2017-09-02       Impact factor: 4.132

Review 8.  Fragile X-associated tremor/ataxia syndrome - features, mechanisms and management.

Authors:  Randi J Hagerman; Paul Hagerman
Journal:  Nat Rev Neurol       Date:  2016-06-24       Impact factor: 42.937

Review 9.  RAN translation-What makes it run?

Authors:  Katelyn M Green; Alexander E Linsalata; Peter K Todd
Journal:  Brain Res       Date:  2016-04-06       Impact factor: 3.252

Review 10.  Pathogenic determinants and mechanisms of ALS/FTD linked to hexanucleotide repeat expansions in the C9orf72 gene.

Authors:  Xinmei Wen; Thomas Westergard; Piera Pasinelli; Davide Trotti
Journal:  Neurosci Lett       Date:  2016-09-13       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.